Medullary thyroid cancer other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
==Key Findings in genetic testing in Medullary Thyroid Cancer== | ==Key Findings in genetic testing in Medullary Thyroid Cancer== | ||
===Nuclear imaging=== | |||
* radioactive iodine: lesions do not concentrate radioactive iodine since the tumour does not arise from thyroid follicular cells | |||
FDG-PET: avid uptake | |||
Tl-201: It has been shown to concentrate Thallium-201 5 | |||
I-123 MIBG: 30% of MTCs show uptake if the thyroid is blocked with Lugol solution prior to the scan | |||
==Key Examples of (Name of Diagnostic Test) in (Disease Name)== | ==Key Examples of (Name of Diagnostic Test) in (Disease Name)== |
Revision as of 13:18, 12 November 2015
Medullary thyroid cancer Microchapters |
Differentiating Medullary thyroid cancer from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Medullary thyroid cancer other diagnostic studies On the Web |
American Roentgen Ray Society Images of Medullary thyroid cancer other diagnostic studies |
Medullary thyroid cancer other diagnostic studies in the news |
Risk calculators and risk factors for Medullary thyroid cancer other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Key Findings in genetic testing in Medullary Thyroid Cancer
Nuclear imaging
- radioactive iodine: lesions do not concentrate radioactive iodine since the tumour does not arise from thyroid follicular cells
FDG-PET: avid uptake Tl-201: It has been shown to concentrate Thallium-201 5 I-123 MIBG: 30% of MTCs show uptake if the thyroid is blocked with Lugol solution prior to the scan